Thyrocare Technologies Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| THYROCARE.BO | METROPOLIS.BO | VIMTALABS.NS | LH | DGX | VIJAYA.NS | |
|---|---|---|---|---|---|---|
| Market cap | 78.02B | 118.56B | 22.68B | 29.86B | 28.22B | 148.08B |
| P/E (TTM) | 54.6 | 53.0 | 28.5 | 30.1 | 25.5 | 72.8 |
| Forward P/E | 31.2 | 36.8 | — | 18.8 | 21.3 | 52.2 |
| Price/book | 14.7 | 7.2 | 4.6 | 3.4 | 3.7 | 14.0 |
| Dividend yield | 1.88% | 0.34% | 0.40% | 0.78% | 1.35% | 0.14% |
| 1-year change | +12.30% | +15.88% | −21.92% | +49.12% | +38.60% | +39.93% |
| Today | −1.02% | −1.85% | +1.90% | +3.92% | +3.49% | +0.92% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All THYROCARE.BO news ›Thyrocare Technologies Q2 profit drops 68 pc to Rs 15 cr
Mumbai, Oct 29 (PTI) Diagnostic laboratory chain Thyrocare Technologies on Thursday reported a 68.16 per cent year-on-year decline in consolidated net profit to Rs 15.22 crore in the September quarter despite revenue growth, due to a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- news18.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.